T/My MPAL blasts overexpressed genes such as SPINK2 which has been associated with immune infiltration in AML [41], and CD82 which has been identified as a driver of chemoresistance in AML [42]. This evidence concerns the gene SPINK2 and acute myeloid leukemia.